Annual report pursuant to Section 13 and 15(d)

Note 19 - Income Taxes

v3.25.0.1
Note 19 - Income Taxes
12 Months Ended
Dec. 31, 2024
Notes to Financial Statements  
Income Tax Disclosure [Text Block]

19. INCOME TAXES 

 

The following is a summary of U.S. and non-U.S. provisions for current and deferred income taxes from continuing operations (dollars in millions):

 

Huntsman Corporation

 

   

Year ended December 31,

 
   

2024

   

2023

   

2022

 

Income tax expense:

                       

U.S.

                       

Current

  $ 1     $ 8     $ 6  

Deferred

    (38 )     (35 )     57  

Non-U.S.

                       

Current

    75       66       91  

Deferred

    23       25       32  

Total

  $ 61     $ 64     $ 186  

 

Huntsman International

 

   

Year ended December 31,

 
   

2024

   

2023

   

2022

 

Income tax expense:

                       

U.S.

                       

Current

  $ 3     $ 9     $ 6  

Deferred

    (39 )     (35 )     59  

Non-U.S.

                       

Current

    75       66       91  

Deferred

    23       25       32  

Total

  $ 62     $ 65     $ 188  

 

The following schedule reconciles the differences between the U.S. federal income taxes at the U.S. statutory rate to our total income tax expense from continuing operations (dollars in millions):

 

Huntsman Corporation

 

   

Year ended December 31,

 
   

2024

   

2023

   

2022

 

(Loss) income from continuing operations before income taxes

  $ (39 )   $ 99     $ 697  
                         

Expected tax (benefit) expense at U.S. statutory rate of 21%

  $ (8 )   $ 21     $ 146  

Change resulting from:

                       

State tax expense, net of federal benefit

    (7 )     (1 )     3  

Non-U.S. tax rate differentials

    (4 )           8  

Income tax settlement related to 2017 U.S. Tax Reform Act

    5              

Loss from liquidation of subsidiaries

    10              

Gain on acquisition of assets, net

    (13 )            

Impact of equity method investments

    (17 )     (28 )     (21 )

Non-U.S. withholding tax on repatriated earnings, interest and royalties, net of U.S. foreign tax credits

    14       12       18  

Tax authority audits and dispute resolutions

    4       5       6  

Non-U.S. income subject to U.S. tax not offset by U.S. foreign tax credits

    (6 )     3       3  

Deferred tax effect of non-U.S. tax rate changes

    (2 )           (2 )

Stock-based compensation

    3             (5 )

Other non-U.S. tax effects, including nondeductible expenses and transfer pricing adjustments

    8       5       (11 )

Other U.S. tax effects, including nondeductible expenses and other credits

    (1 )     2       3  

Change in valuation allowance

    75       45       38  

Total income tax expense

  $ 61     $ 64     $ 186  

 

Huntsman International

 

   

Year ended December 31,

 
   

2024

   

2023

   

2022

 

(Loss) income from continuing operations before income taxes

  $ (36 )   $ 102     $ 700  
                         

Expected tax (benefit) expense at U.S. statutory rate of 21%

  $ (7 )   $ 22     $ 146  

Change resulting from:

                       

State tax expense, net of federal benefit

    (7 )     (1 )     3  

Non-U.S. tax rate differentials

    (4 )           8  

Income tax settlement related to 2017 U.S. Tax Reform Act

    5              

Loss from liquidation of subsidiaries

    10              

Gain on acquisition of assets, net

    (13 )            

Impact of equity method investments

    (17 )     (28 )     (21 )

Non-U.S. withholding tax on repatriated earnings, interest and royalties, net of U.S. foreign tax credits

    14       12       18  

Tax authority audits and dispute resolutions

    4       5       6  

Non-U.S. income subject to U.S. tax not offset by U.S. foreign tax credits

    (6 )     3       3  

Deferred tax effect of non-U.S. tax rate changes

    (2 )           (2 )

Stock-based compensation

    3             (5 )

Other non-U.S. tax effects, including nondeductible expenses and transfer pricing adjustments

    8       5       (11 )

Other U.S. tax effects, including nondeductible expenses and other credits

    (1 )     2       5  

Change in valuation allowance

    75       45       38  

Total income tax expense

  $ 62     $ 65     $ 188  

 

During 2024, the weighted average statutory rate for countries with pre-tax income (primarily our operations in China (25% statutory rate) and Luxembourg (25% statutory rate)) was offset by the weighted average statutory rate for countries with pre-tax losses, resulting in a net tax benefit of $4 million as compared to the 21% U.S. statutory rate reflected in the reconciliation above. During 2023, the weighted average statutory rate for countries with pre-tax income (primarily our operations in China (25% statutory rate), Germany (30% statutory rate) and Luxembourg (25% statutory rate)) was offset by the weighted average statutory rate for countries with pre-tax losses, resulting in an immaterial difference as compared to the 21% U.S. statutory rate reflected in the reconciliation above. During 2022, the weighted average statutory rate for countries with pre-tax income (in primarily our operations in China (25% statutory rate), Germany (30% statutory rate) and Luxembourg (25% statutory rate)) was higher than the weighted average statutory rate for countries with pre-tax losses, resulting in a net expense of $8 million, as compared to the 21% U.S. statutory rate reflected in the reconciliation above.

 

Under the U.S. Tax Reform Act’s global intangible low-taxed income (“GILTI”) provision, our non-U.S. operations are generally subject to U.S. tax. We have elected to treat the GILTI as a current-period expense when incurred. The stated purpose of the GILTI rules is to generate additional U.S. tax related to income in non-U.S. jurisdictions which incur less than a blended 13.125% non-U.S. tax rate. Our non-U.S. income is subject to a blended rate greater than 13.125%; however, in practice, the GILTI regulations result in additional tax liability from expense allocations which limit our ability to utilize foreign tax credits against the GILTI inclusion. For 2024, 2023 and 2022, we incurred a tax benefit of $6 million, tax expense of $3 million and tax expense of $3 million, respectively, resulting from these expense allocations, net of other U.S. taxation on foreign operations and foreign tax credits. 

 

The components of (loss) income from continuing operations before income taxes were as follows (dollars in millions):

 

Huntsman Corporation

 

   

Year ended December 31,

 
   

2024

   

2023

   

2022

 

U.S.

  $ (176 )   $ (155 )   $ 273  

Non-U.S.

    137       254       424  

Total

  $ (39 )   $ 99     $ 697  

 

 

Huntsman International

 

   

Year ended December 31,

 
   

2024

   

2023

   

2022

 

U.S.

  $ (173 )   $ (152 )   $ 276  

Non-U.S.

    137       254       424  

Total

  $ (36 )   $ 102     $ 700  

 

Components of deferred income tax assets and liabilities were as follows (dollars in millions):

 

Huntsman Corporation

 

   

December 31,

 
   

2024

   

2023

 

Deferred income tax assets:

               

Net operating loss carryforwards

  $ 289     $ 234  

Operating leases

    95       92  

Pension and other employee compensation

    57       65  

Deferred interest

    104       78  

Capitalized research and development costs

    56       44  

Property, plant and equipment

    25       22  

Intangible assets

    9       16  

Intercompany prepayments

    4       28  

Other, net

    49       41  

Total

  $ 688     $ 620  

Deferred income tax liabilities:

               

Property, plant and equipment

  $ (284 )   $ (267 )

Operating leases

    (95 )     (93 )

Intangible assets

    (74 )     (80 )

Pension and other employee compensation

    (52 )     (28 )

Outside basis difference in subsidiaries

    (42 )     (41 )

Unrealized currency gains

    (16 )     (8 )

Other, net

    (5 )     (13 )

Total

  $ (568 )   $ (530 )

Net deferred tax asset before valuation allowance

  $ 120     $ 90  

Valuation allowance—net operating losses, deferred interest and other

    (255 )     (221 )

Net deferred tax liability

  $ (135 )   $ (131 )

Non-current deferred tax asset

  $ 69     $ 112  

Non-current deferred tax liability

    (204 )     (243 )

Net deferred tax liability

  $ (135 )   $ (131 )

 

Huntsman International

 

   

December 31,

 
   

2024

   

2023

 

Deferred income tax assets:

               

Net operating loss carryforwards

  $ 288     $ 234  

Operating leases

    95       92  

Pension and other employee compensation

    56       65  

Deferred interest

    104       78  

Capitalized research and development costs

    55       44  

Property, plant and equipment

    25       22  

Intangible assets

    9       16  

Intercompany prepayments

    4       28  

Other, net

    49       41  

Total

  $ 685     $ 620  

Deferred income tax liabilities:

               

Property, plant and equipment

  $ (284 )   $ (267 )

Operating leases

    (95 )     (93 )

Intangible assets

    (74 )     (80 )

Pension and other employee compensation

    (52 )     (28 )

Outside basis difference in subsidiaries

    (42 )     (41 )

Unrealized currency gains

    (16 )     (8 )

Other, net

    (5 )     (17 )

Total

  $ (568 )   $ (534 )

Net deferred tax asset before valuation allowance

  $ 117     $ 86  

Valuation allowance—net operating losses, deferred interest and other

    (255 )     (221 )

Net deferred tax liability

  $ (138 )   $ (135 )

Non-current deferred tax asset

  $ 69     $ 112  

Non-current deferred tax liability

    (207 )     (247 )

Net deferred tax liability

  $ (138 )   $ (135 )

 

We evaluate deferred tax assets to determine whether it is more likely than not that they will be realized. Valuation allowances are reviewed each period on a tax jurisdiction basis and analyzed to determine whether there is sufficient positive or negative evidence to support a change in judgment about the realizability of the related deferred tax assets. These conclusions require significant judgment. In evaluating the objective evidence that historical results provide, we consider cumulative income or losses during the applicable three-year period. Cumulative losses incurred over the three-year period limits our ability to consider other evidence such as our projections for the future. Our judgments regarding valuation allowances are also influenced by factors outside of business results, including the costs and risks associated with any tax planning associated with utilizing a deferred tax asset.

 

With the negative economic impacts of recent events, including economic challenges in Europe, we established a $10 million valuation allowance against the entire net deferred tax asset of our largest tax filing group in Germany as of December 31, 2024. We also established $13 million of significant valuation allowances on certain net deferred tax assets in Luxembourg in the fourth quarter of 2024 as a result of changes in estimated future taxable income resulting from decreased intercompany receivables and, therefore, decreased income in Luxembourg, our primary treasury center outside of the U.S. We also had miscellaneous non-significant valuation allowance establishments totaling $6 million in 2024. We established a $14 million valuation allowance against the entire net deferred tax asset in the U.K. as of December 31, 2023, and a $49 million valuation allowance against the entire net deferred tax asset in the Netherlands as of December 31, 2022.

 

We have gross net operating losses (“NOLs”) of $960 million ($239 million tax-effected) in various non-U.S. jurisdictions. While the majority of the non-U.S. NOLs have no expiration date, $37 million ($6 million tax-effected) have a limited life (of which $1 million (immaterial tax effect) are subject to a valuation allowance), of which none are scheduled to expire in 2025. We had no NOLs expire unused in 2024. 

 

We have gross U.S. federal NOLs of $182 million ($38 million tax-effected), the majority of which are not subject to expiration. We expect to be able to utilize all of these NOLs, and therefore they are not subject to a valuation allowance.

 

Included in the $960 million of gross non-U.S. NOLs is $224 million ($53 million tax-effected) attributable to our Luxembourg entities. As of December 31, 2024, due to the uncertainty surrounding the realization of the benefits of these losses, there is a valuation allowance of $29 million against these net tax-effected NOLs of $53 million.

 

We have $11 million tax effected federal and state capital loss carryovers, all of which are subject to a valuation allowance. Capital loss carryovers may only be utilized against capital gains and have a 5-year carryforward period, generally expiring at the end of 2028. 

 

We have gross U.S. federal deferred interest deductions of $148 million ($31 million tax-effected), which are limited to deduction of 30% of adjusted taxable income, but are not subject to expiration. We expect to be able to utilize all of these deferred interest deductions and, therefore, they are not subject to a valuation allowance. Deferred interest deductions of $65 million, tax-effected in the Netherlands, are deduction-limited based on a percentage of EBITDA, are not subject to expiration and which are subject to a full valuation allowance.

 

 

Uncertainties regarding expected future income in certain jurisdictions could affect the realization of deferred tax assets in those jurisdictions and result in additional valuation allowances in future periods, or, in the case of unexpected pre-tax earnings, the release of valuation allowances in future periods.

 

The following is a summary of changes in the valuation allowance (dollars in millions):

 

Huntsman Corporation

 

   

2024

   

2023

   

2022

 

Valuation allowance as of January 1

  $ 221     $ 169     $ 131  

Valuation allowance as of December 31

    255       221       169  

Net increase

    (34 )     (52 )     (38 )

Foreign currency movements

    (13 )     3       (4 )

Decrease to deferred tax assets with no impact on operating tax expense, including an offsetting (decrease) increase to valuation allowances

    (28 )     4       4  

Change in valuation allowance per rate reconciliation

  $ (75 )   $ (45 )   $ (38 )

Components of change in valuation allowance affecting tax expense:

                       

Pre-tax income and losses in jurisdictions with valuation allowances resulting in no tax expense or benefit

  $ (46 )   $ (30 )   $ 13  

Releases of valuation allowances in various jurisdictions

          1        

Establishments of valuation allowances in various jurisdictions

    (29 )     (16 )     (51 )

Change in valuation allowance per rate reconciliation

  $ (75 )   $ (45 )   $ (38 )

 

Huntsman International

 

   

2024

   

2023

   

2022

 

Valuation allowance as of January 1

  $ 221     $ 169     $ 131  

Valuation allowance as of December 31

    255       221       169  

Net increase

    (34 )     (52 )     (38 )

Foreign currency movements

    (13 )     3       (4 )

Decrease to deferred tax assets with no impact on operating tax expense, including an offsetting (decrease) increase to valuation allowances

    (28 )     4       4  

Change in valuation allowance per rate reconciliation

  $ (75 )   $ (45 )   $ (38 )

Components of change in valuation allowance affecting tax expense:

                       

Pre-tax income and losses in jurisdictions with valuation allowances resulting in no tax expense or benefit

  $ (46 )   $ (30 )   $ 13  

Releases of valuation allowances in various jurisdictions

          1        

Establishments of valuation allowances in various jurisdictions

    (29 )     (16 )     (51 )

Change in valuation allowance per rate reconciliation

  $ (75 )   $ (45 )   $ (38 )

 

The following is a reconciliation of our unrecognized tax benefits (dollars in millions):

 

   

2024

   

2023

 

Unrecognized tax benefits as of January 1

  $ 5     $ 57  

Gross increases and decreases—tax positions taken during a prior period

          (50 )

Gross increases and decreases—tax positions taken during the current period

    1        

Reductions resulting from the lapse of statues of limitations

    (1 )     (2 )

Unrecognized tax benefits as of December 31

  $ 5     $ 5  

 

As of December 31, 2024 and 2023, the amount of unrecognized tax benefits (not including interest and penalties) which, if recognized, would affect the effective tax rate is $2 million and $5 million, respectively. During 2023, we recorded a $32 million decrease to our unrecognized tax benefits related to the timing of tax losses on our Venator investment. This decrease was offset by a decrease in net deferred tax assets and, therefore, did not affect income tax expense. 

 

On February 28, 2023, we completed the sale of our Textile Effects Business to Archroma. Due to the sale of these legal entities, our unrecognized tax benefits (and associated interest and penalties) transferred to Archroma with no corresponding income tax benefit for the reduction since we have provided indemnification for pre-acquisition income taxes.

 

During 2024, we concluded and settled tax examinations in the U.S. (federal and various states), Belgium, China, Germany and Italy. During 2023, we concluded and settled tax examinations in the U.S. (federal and various states), Germany, Indonesia, Singapore and Thailand. During 2022, we concluded and settled tax examinations in the U.S. (federal and various states), China and Japan. 

 

During 2024, for unrecognized tax benefits that impact tax expense, we recorded no net change. During 2023, for unrecognized tax benefits that impact tax expense, we recorded a net decrease in unrecognized tax benefits with a corresponding income tax benefit (not including interest and penalties) of $1 million. During 2022, for unrecognized tax benefits that impact tax expense, we recorded a net increase in unrecognized tax benefits with a corresponding income tax expense (not including interest and penalties) of $3 million. 

 

We recognized accrued interest related to unrecognized tax benefits in income tax expense as provided below (dollars in millions):

 

   

Year ended December 31,

 
   

2024

   

2023

   

2022

 

Interest included in tax expense

  $ 2     $ 3     $ 3  

 

   

December 31,

 
   

2024

   

2023

 

Accrued liability for interest

  $ 8     $ 6  

 

We conduct business globally, and as a result, we file income tax returns in U.S. federal, various U.S. state and various non-U.S. jurisdictions. The following table summarizes the tax years that remain subject to examination by major tax jurisdictions:

 

Tax jurisdiction

 

Open tax years

Belgium

 

2022 and later

China

 

2014 and later

Germany

 

2018 and later

Hong Kong

 

2018 and later

India

 

2022 and later

Italy

 

2019 and later

Mexico

 

2022 and later

Switzerland

 

2017 and later

The Netherlands

 

2020 and later

United Kingdom

 

2022 and later

United States federal

 

2017 and later

 

Certain of our U.S. and non-U.S. income tax returns are currently under various stages of audit by applicable tax authorities and the amounts ultimately agreed upon in resolution of the issues raised may differ materially from the amounts accrued.

 

We estimate that it is not reasonably possible that our unrecognized tax benefits would significantly change within 12 months of the reporting date.

 

In connection with the provisions of U.S. Tax Reform, all non-U.S. earnings have generally been subject to U.S. tax and may be repatriated without incurring additional U.S. tax liability. Such repatriation may potentially be subject to limited foreign withholding taxes. We intend to continue to invest most of these earnings indefinitely within the local countries and do not expect to incur any significant additional taxes. There are certain countries where we do intend to repatriate some of our earnings, and we have accrued all withholding taxes for such amounts.